background: Hypoxia of the human endometrium is a physiologic event occurring during the perimenstrual period and the local stimulus for angiogenesis. The aim of this study was to investigate the effects of hypoxic stress on the regulation of vascular endothelial growth factor (VEGF) and stromal cell-derived factor-1 (SDF-1/CXCL12), and the potential role of hypoxia-inducible factor-1a (HIF-1a) in the endometrium.
Introduction
The human endometrium is a dynamic tissue that undergoes regular cycles of menstruation, menstrual repair, proliferation and secretory differentiation. Angiogenesis is important in the cyclical repair and regeneration of the endometrium during the menstrual cycle (Aberdeen et al., 2008) . Hypoxia in the endometrial tissues is a physiologic event that occurs during the premenstrual period. Local hypoxia is a major regulator of endometrial angiogenesis and remodeling during menstruation (Salamonsen, 2003) . The complex processes of angiogenesis are presumably tightly regulated by multiple system controls that can be switched on and off within a short period.
Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis and vascular function. Recent studies have reported the role of VEGF in the early angiogenic processes associated with postmenstrual regeneration of endometrium (Fan et al., 2008) . VEGF is essential for the rapid burst of angiogenesis that occurs during postmenstrual repair and early proliferative phases in the primate endometrium and further plays a role in re-epithelialization of the endometrium (Fan et al., 2008) . Stromal cell-derived factor-1 (SDF-1, also known as CXCL12) and VEGF play important roles in angiogenesis. In the vasculature, SDF-1 functions as a potent inducer of angiogenesis, stimulating endothelial cell proliferation and cell survival (Salcedo et al., 1999) . VEGF and SDF-1 interact synergistically to promote the functions of vascular endothelial cells, such as cell migration, cell survival and changes in gene expression (Salcedo et al., 1999; Bachelder et al., 2002; Nishigaki et al., 2010) . VEGF and SDF-1 are present in the human endometrium (Sugino et al., 2002; Ruiz et al., 2010) . SDF-1 has been shown to be up-regulated in many damaged tissues as part of the injury response and is thought to channel stem and progenitor cells to promote repair (Burger and Kipps, 2006) . As shown in several recent studies on SDF-1 for human endometrial function, SDF-1 may play crucial roles in endometrial proliferation, embryo implantation and leukocyte recruitment to the endometrium (Dominguez et al., 2003; Wu et al., 2005; Tsutsumi et al., 2011) . In view of the pleiotropic functions, SDF-1 and VEGF are thought to significantly influence angiogenesis and endometrial vascularization. Therefore, in this study, we investigated VEGF and SDF-1 and their potential functions as the angiogenic factors that contribute to the regulation of angiogenesis and proliferation of the human endometrium.
Previous studies suggested that the expression of VEGF and SDF-1 in the endometrium is regulated by female sex steroids (Okada et al., 2009; Tsutsumi et al., 2011) . Estradiol (E 2 ) induced mRNA and protein production of VEGF and SDF-1 in primary cultures of human endometrial stromal cells (ESCs), whereas progesterone had inhibitory effects on E 2 -induced VEGF and SDF-1 production . On the other hand, hypoxia is believed to be an important regulator of angiogenesis and stimulates mRNA expression and production of VEGF and SDF-1 in other tissues (Martin et al., 2010; Dong et al., 2011) .
Hypoxia-inducible factor-1a (HIF-1a) is a transcription factor known to play a major role in the cellular response to hypoxia. HIF-1a protein is suppressed in cells under normoxic conditions (20 -22% O 2 ) and its expression is rapidly induced by hypoxic conditions (1 -2% O 2 ). In normoxia, HIF-1a is post-translationally hydroxylated by prolyl hydroxylases in the oxygen-dependent degradation domain. This interaction results in ubiquitination and subsequent proteasome degradation of HIF-1a. Hypoxia inhibits the hydroxylation steps, which prevents the interaction of HIF-1a with the von HippelLindau tumor suppressor protein, which recruits a ubiquitin -ligase complex, and the subsequent ubiquitination and degradation of HIF-1a (Ivan et al., 2001; Jaakkola et al., 2001) . VEGF and a number of other angiogenic genes have been shown to be transcriptionally regulated by HIF-1a (Semenza, 2011) . In the human endometrium, HIF-1a protein is abundant in glandular and stromal cells in the functional layer during the late secretory and menstrual phases (Critchley et al., 2006) . However, the regulation of VEGF and SDF-1 via HIF-1a activation under hypoxic condition in the human endometrium remains poorly understood.
We hypothesized that hypoxia is involved in the regulation of VEGF or SDF-1 in the endometrium. In the present study, we evaluated the effects of hypoxia on the expression of VEGF and SDF-1 by using ESCs in culture and investigated the potential role of HIF-1a in the regulation of these angiogenic factors under hypoxic conditions.
Materials and Methods

Tissue collection and culture of ESCs
All human tissues were obtained using a protocol for the protection of human subjects approved by the ethical committee of Kansai Medical University, Japan, together with informed consent from all patients and in accordance with the Declaration of Helsinki. Human endometrial tissues were obtained from 22 patients, aged 34 -47 years, in the proliferative phase, with regular menstrual cycles, who underwent hysterectomies for the treatment of myoma uteri without hormonal therapy. ESCs were purified by the standard enzyme digestion method as described previously . ESCs were cultured in Dulbecco's modified Eagle's medium (DMEM)/F-12 medium supplemented with 10% fetal calf serum (FCS) (HyClone, Logan, UT, USA), 100 IU/ml penicillin and 100 mg/ml streptomycin (Invitrogen, Carlsbad, CA, USA) at 378C under a humidified atmosphere of 5% CO 2 in air. The culture medium was replaced 30 min after plating to reduce epithelial cell contamination. The percentage of vimentin-positive cells in confluent ESCs was .99% by immunohistochemical staining as described previously (Okada et al., 2001) .
Hypoxic stimulus and reagents for ESCs
After passage 0 -1 when ESCs were nearly confluent, cells were trypsinized and re-plated in 6-well plates (1 × 10 6 cells/well) for real-time PCR analyses, 24-well plates (2 × 10 5 cells/well) for ELISA. ESCs were cultured in 10% FCS-supplemented DMEM/F-12 medium under hypoxic conditions (2% O 2 , 5% CO 2 and 93% N 2 ) or normoxic conditions (5% CO 2 and 95% air), resulting in an oxygen concentration of 20%. In drug-induced hypoxic experiments, ESCs were cultured in 10% FCS-supplemented medium containing various amounts of cobalt chloride (CoCl 2 , a hypoxia-mimicking agent; 0.1 -100 mmol/l; Wako, Osaka, Japan), echinomycin (a HIF-1a inhibitor; 0.1 -100 nmol/l; ENZO Life Sciences, NY, USA) and/or dimethylsulfoxide as vehicle control under 5% CO 2 in air. The supernatant was collected after stimulation and stored at 2808C until assayed. Each experiment was repeated at least three times with different cell preparations.
RNA extraction and real-time PCR analysis
Total RNA was isolated from cultured ESCs using an RNeasy Minikit (Qiagen GmbH, Hilden, Germany) according to the manufacturer's instructions. Quantitative real-time PCR was performed using the SYBR green I nucleic acid Gel Stain (Roche, Diagnostics GmbH, Mannheim, Germany) as described previously (Nakamoto et al., 2005) . Elongation factor-1a (EF-1a) was used as an internal control, as it is a valid reference 'housekeeping' gene for transcription profiling, which is also used for realtime PCR experiments. Forward (F) and reverse (R) primers used in this study were as follows: VEGF, 5
. PCR of all standards and samples was performed using duplicate reactions, after which a melting curve analysis was performed to monitor PCR product purity. In order to eliminate the possibility of contamination with genomic DNA during extraction of total RNA, a control reaction with each primer pair was performed at the same time under identical conditions without reverse transcription, and no amplification was detected.
VEGF and SDF-1 assay by ELISA
The release of VEGF and SDF-1 into cell culture supernatants was assessed using commercially available sandwich ELISA kits (Quantikine ELISA kit; R&D systems, Minneapolis, MN, USA) according to the manufacturer's instructions. Intra-assay and inter-assay coefficients of variation in cell culture supernatants were 2.2 and 8.9% for VEGF and 3.3 and 7.2% for SDF-1, respectively.
Lactate dehydrogenase release analysis
Measurement of lactate dehydrogenase (LDH) release was conducted to examine the effect of drug treatment on cell viability. After exposure to various treatments for 48 h, conditioned media were collected. The release of LDH into culture media was measured using a specific Cytotoxicity Detection kit (Roche) according to the manufacturer's instructions. Absorbance data were obtained with a 490 nm filter and a 620 nm filter as reference wavelength. LDH release as high (positive) control was determined by cell culture media containing 5% Tween 20.
Western blot analysis
For analysis of HIF-1a protein levels, cultured cells treated with CoCl 2 and echinomycin were homogenized in lysis buffer containing Mammalian Protein Extraction Reagent (Thermo Fisher Scientific Inc., Rockford, IL, USA) and protease inhibitor cocktail. Samples were subjected to 7.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to Immun-Blot polyvinylidene diflouride Membrane (Bio-Rad, Laboratories, Inc., Hercules, CA, USA). Non-specific-binding sites were blocked with 10% skim milk powder in Tris-buffered saline for 30 min. Blots were then incubated for 1 h at room temperature with rabbit monoclonal HIF-1a antibody (1:1000; Epitomics, Inc., Burlingame, CA, USA) or mouse monoclonal b-actin antibody (1:5000; Sigma-Aldrich Corp., St. Louis, MO, USA) as a primary antibody, and anti-rabbit immunoglobulin (Ig)G peroxidase-labeled secondary antibody (1:5000; GE Healthcare Life Science, St. Giles, UK) or anti-mouse IgG peroxidase-labeled secondary antibody (1:10000; GE Healthcare Life Science) as a secondary antibody. Immune complexes were visualized by enhanced chemiluminescence plus Western Blotting Detection Reagents (GE Healthcare Life Science). We analyzed the protein levels using ImageJ software and visualized quantitatively. ImageJ is a public domain image-processing program developed by the National Institutes of Health and is freely available at http://rsbweb.nih.gov/ij. Fold increase was calculated by dividing the relative expression of HIF-1a by the relative expression of b-actin.
Statistical analysis
Data are expressed as mean + SEM. Results were analyzed with a statistical software package, StatView II version 4.0 (Abacus Concepts, Berkeley, CA, USA). Differences in the measured parameters across the different groups were statistically assessed using analysis of variance with repeated measurements, followed by Fisher's protected least significant difference, multiple range test. A level of P , 0.05 was considered statistically significant.
Results
Effects of hypoxia on mRNA expression and protein secretion of VEGF and SDF-1 in ESCs
To characterize the effects of hypoxia on VEGF and SDF-1 mRNA expression, we analyzed cultured ESCs under hypoxic (2% O 2 ) or normoxic (20% O 2 ) conditions for 48 h. Real-time PCR analysis demonstrated that hypoxia caused a significant increase in the levels of VEGF mRNA expression (Fig. 1A) . In contrast, SDF-1 mRNA expression was significantly inhibited in the hypoxic condition (Fig. 1B) . As shown in Fig. 1C and D, the levels of VEGF protein significantly increased in response to hypoxia, whereas those of SDF-1 were significantly attenuated. The temporal release of VEGF and SDF-1 from ESCs in response to hypoxia is shown in Fig. 2 . Hypoxia caused a significant increase of VEGF production after 6 h of culture compared with normoxia, and this effect continued to increase until the end of the study at 48 h. In contrast, SDF-1 production was significantly suppressed after 24 h in response to hypoxia, and this effect continued until the end of the study at 48 h. These findings suggest that hypoxia simultaneously stimulates VEGF production and inhibits SDF-1 production in cultured ESCs.
Effects of CoCl 2 on VEGF and SDF-1 secretion from ESCs
The effects of hypoxia on secretion of VEGF and SDF-1 were further confirmed by culturing ESCs in the presence of CoCl 2 , which induced environment-mimicking hypoxic conditions. ESCs were incubated with various doses of CoCl 2 for 48 h. As shown in Fig. 3A , 1 mM CoCl 2 had no effect, but VEGF production was induced by 10 mM CoCl2, and 100 mM CoCl 2 strongly induced VEGF production. On the other hand, CoCl 2 significantly attenuated SDF-1 production from ESCs in a dose-dependent manner, when compared with controls (Fig. 3B) . The maximal effect was observed at 100 mM, but a significant decrease was observed at 0.1 mM. In order to exclude the potential toxicity of CoCl 2 on ESCs, we assessed cell viability using LDH assay. CoCl 2 at a concentration of 100 mM did not increase LDH release from ESCs (data not shown). Therefore, in all subsequent experiments, we chose the 100 mM concentration of CoCl 2 to mimic hypoxic conditions.
CoCl 2 treatment increases HIF-1a protein levels in ESCs
We then evaluated potential mechanisms that might explain the effect of CoCl 2 on VEGF and SDF-1 production in ESCs. It is well known that CoCl 2 can mimic HIF-1 activation through inhibition of HIF-1a degradation. By using western blot analysis, we determined whether the addition of CoCl 2 led to an increase in the levels of HIF-1a proteins in the ESCs. As shown in Fig. 4A , CoCl 2 significantly induces the expression of HIF-1a protein levels at 2 and 6 h in ESCs, whereas the addition of a vehicle to the culture medium had no effect. The highest expression of HIF-1a protein was observed at 6 h, and the levels had declined by 24 h. This experiment was repeated three times with different batches of cells, and the results were similar (Fig. 4B) .
Effects of echinomycin on CoCl 2 -mediated VEGF and SDF-1 secretion from ESCs
To demonstrate the role of HIF-1a in CoCl 2 -mediated VEGF and SDF-1 protein production, we used echinomycin, a small-molecule inhibitor of HIF-1a activity. It has been reported that echinomycin specifically inhibits DNA binding of HIF-1a by directly interacting with the core sequence within the hypoxia-response element (HRE) of the target gene. We monitored the secretion of VEGF and SDF-1 under hypoxic conditions induced by CoCl 2 with or without the addition of echinomycin in ESCs. The 100 nM concentration of echinomycin almost completely inhibited the induction of VEGF under the hypoxic condition induced by CoCl 2 (Fig. 5A) . However, the echinomycin treatment did not affect the production of SDF-1 (Fig. 5B) . The viability of cells, as measured by LDH release assay, remained unchanged in ESCs treated with CoCl 2 and/or echinomycin in comparison with the untreated cells (Fig. 5C) . Furthermore, to rule out the possibility that the decrease of VEGF by echinomycin depends on the down-regulation of HIF-1a protein levels, we performed western blotting analysis to examine the HIF-1a protein levels in ESCs treated with CoCl 2 and/or echinomycin for 6 h. As shown in Fig. 6A , CoCl 2 induced HIF-1a protein accumulation, which did not change with the addition of echinomycin. This experiment was repeated three times with different batches of cells, and the results were similar (Fig. 6B) . These results show that echinomycin did not affect HIF-1a protein levels and inhibition of hypoxic induction of VEGF production. In conclusion, our results reinforced the hypothesis that HIF-1a plays a major role in regulating the expression of VEGF under hypoxic conditions in ESCs.
Discussion
The present study shows that hypoxia simultaneously induces the expression of mRNA and production of VEGF and attenuates the expression and production of SDF-1 in human ESCs. In addition, similar changes in VEGF and SDF-1 were observed in ESCs with CoCl 2 stimulation, a chemical hypoxia-mimicking agent, which prevents the proteasomal degradation of HIF-1a proteins to create a hypoxia-like condition. CoCl 2 simply reverses the high level of degradation induced by 20% O 2 , restoring the presence of a pool of endogenous HIF-1a within ESCs. Our study shows that 100 mM CoCl 2 is sufficient to increase the HIF-1a level and VEGF production in ESCs but concentrations of CoCl 2 up to even 500 mM have been used in studies of HIF-1a (Cho et al., 2005; Ardyanto et al., 2006) . It has been demonstrated that hypoxia stimulated VEGF mRNA expression in ESCs (Popovici et al., 1999; Sharkey et al., 2000) , which is consistent with our data. These studies suggest that the effect of hypoxia on VEGF production from ESCs might have physiologic relevance in the process of menstruation and in postmenstrual endometrial repair and angiogenesis. To the best of our knowledge, our study is the first to demonstrate that hypoxic stress inhibits SDF-1 in human ESCs. These findings are surprising because hypoxia has been shown to induce the production of several angiogenic stimulators, such as VEGF and SDF-1, in endothelial cells or cancer cells (Schioppa et al., 2003; Takenaga, 2011) . Taking into account our present findings, ESCs are suggested to be able to control physiologic angiogenesis in the endometrium by regulating the production of angiogenic factors.
HIF-1a plays a critical role in cellular responses to hypoxia. HIF-1a activation by the hypoxic microenvironment contributes to the induction or repression of the activity of genes involved in different cellular functions, such as cell survival, oxygen homeostasis, proliferation, angiogenesis, glucose metabolism and apoptosis (SzablowskaGadomska et al., 2011) . Both studies in cultured cells and animal models have demonstrated that HIF-1a was involved in the increased Figure 1 The effect of hypoxia on mRNA expression of VEGF (A) and SDF-1 (B) in ESCs. ESCs were cultured in normoxia (20% O 2 ) or hypoxia (2% O 2 ) for 48 h. VEGF and SDF-1 mRNA levels were analyzed by real-time PCR analysis and calculated after normalization to EF-1a mRNA expression. The effect of hypoxia on VEGF (C) and SDF-1 (D) production in ESCs. The ELISA measured VEGF and SDF-1 concentrations in the culture medium. The effect of normoxia on VEGF and SDF-1 production is assigned a potency of 100%. Results are combined data of four experiments with different cell preparations and each value represents mean + SEM. *P , 0.01 versus normoxia.
expression of VEGF and SDF-1 in response to hypoxia and ischemia (Yamakawa et al., 2003; Ceradini and Gurtner, 2005) . HIF-1a has been shown to directly bind to HREs in the promoters of the genes encoding VEGF. In the human endometrium, HIF-1a protein is expressed with increasing intensity from the premenstrual to the menstrual phase but no HIF-1a immunoreactivity was detected in endometrial biopsies from the proliferative phase (Critchley et al., 2006) . The temporal and spatial distribution of HIF-1a protein would thus seem to be related to the process of menstruation. In fact, hypoxia has been shown to induce VEGF mRNA expression via HIF-1a activation in the human endometrium (Yoshie et al., 2009) .
The present study demonstrates that SDF-1 production is attenuated by hypoxia in human ESCs. Our previous studies showed that SDF-1 and VEGF were up-regulated by E 2 (Okada et al., 2009 Tsutsumi et al., 2011) and that progesterone inhibited E 2 -induced SDF-1 and VEGF expression in ESCs. E 2 affects angiogenesis and growth in the human endometrium via a synergistic pathway involving both VEGF and SDF-1. With regard to SDF-1, steroid hormones rather than hypoxia may be the main regulator for its secretion in ESCs. These results indicate that SDF-1 plays a more important role for endometrial proliferation than repair of the endometrium during the perimenstrual period. We have previously described SDF-1 as a candidate factor involved in the epithelial-stromal interaction of the human endometrium and concluded that SDF-1 might be actively involved in its proliferation (Tsutsumi et al., 2011) .
The present study showed that hypoxia-induced VEGF secretion was significantly attenuated by echinomycin. Echinomycin is a sequence-specific DNA-binding agent that binds to the HRE site within the promoters of HIF-1a target genes and selectively inhibits HIF-1a binding activity (Kong et al., 2005) . We confirmed that the inhibition of VEGF production by echinomycin did not affect HIF-1a protein levels and cell viability. These results indicate that echinomycin can inhibit VEGF expression, which is a key regulator of angiogenesis and vascular function in the human endometrium, without changing the HIF-1a protein level and causing cell toxicity. These results demonstrate that echinomycin may be a potential therapeutic agent for HIF-1a-dependent disorders and normal function. In addition, the inhibition of HIF-1a function by echinomycin has been shown to block ovulation in mice, and echinomycin reduced the expression of VEGF, a key factor controlling angiogenesis during ovulation (Kim et al., 2009) . Furthermore, phases I and II cancer therapeutic trials of echinomycin have been based on observations that echinomycin exhibits potent anti-proliferative effects on several tumor-derived cell lines (Foster et al., 1985; Gradishar et al., 1995) .
What is the mechanism underlying the inhibition of SDF-1 production under hypoxic conditions? We showed that hypoxia attenuated SDF-1 production in ESCs but echinomycin has no effect on this suppression. Hypoxia is known to induce the activation of transcription factors, including HIF-1a, activator protein 1 (AP-1) and nuclear factor (NF)-kB (Lukiw et al., 2003; Martin et al., 2004) . As previously shown, echinomycin specifically inhibited HIF-1a-dependent, but not AP-1-or NF-kB-dependent, DNA-binding activity (Kong et al., 2005) . Therefore, we speculate that the inhibitory effect on SDF-1 production by hypoxia is caused by the action of transcription factor AP-1 or NF-kB. However, the precise mechanisms by which hypoxia acts to inhibit SDF-1 production are not fully understood.
We revealed that hypoxia significantly increased the VEGF production levels and attenuated SDF-1 production in human ESCs. These results are in agreement with earlier studies describing that the VEGF mRNA level was increased and the SDF-1 mRNA level was decreased in culture cells of hypoxic rat inner ear (Gross et al., 2009) . This induction of ESC-derived VEGF production may contribute to the early angiogenic processes associated with postmenstrual regeneration of endometrium (Fan et al., 2008) . The decrease of SDF-1 production may be involved in the mobilization of local endothelial progenitor or stem cells in the regenerating endometrium (Semerad et al., 2005; Gross et al., 2009) .
In summary, we showed that hypoxia simultaneously acts to increase VEGF via HIF-1a and to decrease SDF-1 in a HIF-1a-independent manner in ESCs. These data indicate a potential mechanism for the action of hypoxic conditions that could influence angiogenesis of the human endometrium. Moreover, echinomycin Total cell lysates obtained from ESCs cultured with either control or CoCl 2 (100 mM) for 2, 6, 24 and 48 h were loaded onto a 7.5% sodium dodecyl sulfate-polyacrylamide gel. (B) The protein levels were quantified using ImageJ. Columns and vertical bars represent the mean + SEM for combined data of three separate experiments with different cell preparations. *P , 0.05, **P , 0.01 versus control. can inhibit VEGF production in ESCs, without affecting the HIF-1a protein level, SDF-1 production and cell toxicity. These findings suggest a unique therapeutic potential for echinomycin as an inhibitor of HIF-1a activation. The knowledge of angiogenic factors in the endometrium will have an impact on the development of strategies for inhibiting or augmenting the growth of blood vessels in normal and pathologic human reproductive processes. In addition, understanding the role of O 2 tension on the regulation of these factors might help clarify the mechanism of regulation of physiologic angiogenesis in normal tissues. Hypoxia affects the angiogenic factors
